• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Ind-Swift Laboratories Ltd

+ Add to Watchlist

ISL:IN

39.30 INR 0.15 0.38%

As of 07:05:56 ET on 04/17/2014.

Snapshot for Ind-Swift Laboratories Ltd (ISL)

Open: 38.50 Day's Range: 38.10 - 40.70 Volume: 260,159
Previous Close: 39.15 52wk Range: 19.25 - 49.20 1-Yr Rtn: -10.27%

Stock Chart for ISL

No chart data available.
  • ISL:IN 39.25
  • 1D
  • 1M
  • 1Y
39.15
Interactive ISL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ISL

Current P/E Ratio (ttm) -
Estimated P/E(03/2014) -
Relative P/E vs. SENSEX -
Earnings Per Share (INR) (ttm) -30.0900
Est. EPS (INR) (03/2014) -
Est. PEG Ratio -
Market Cap (M INR) 1,609.85
Shares Outstanding (M) 40.96
30 Day Average Volume 273,985
Price/Book (mrq) 0.1808
Price/Sale (ttm) 0.1356
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 1.0000
Dividend Ex-Date 09/20/2011
5 Year Dividend Growth -
Next Earnings Announcement 06/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ISL

No data available

Company Profile & Key Executives for ISL

Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates. The Company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.

N R MunjalVice Chairman/Mng Dir/CEOHimanshu JainJoint Managing Director
N K BansalChief Financial OfficerLalit K WadhwaChief Operating Officer
More Company Profile & Key Executives for ISL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil